JOSEP
REDON MAS
CATEDRÁTICO/A DE UNIVERSIDAD
Wrocław Medical University
Breslavia, PoloniaPublicacións en colaboración con investigadores/as de Wrocław Medical University (2)
2021
-
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes
European heart journal, Vol. 42, Núm. 6, pp. 700-710
2019
-
Rationale and design of the EMPERIAL-Preserved and EMPERIAL-Reduced trials of empagliflozin in patients with chronic heart failure
European Journal of Heart Failure, Vol. 21, Núm. 7, pp. 932-942